Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reiner Schaumann

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
International Journal of Hygiene and Environmental Health|November 6, 2007
Molecular typing of clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and random primer PCR fingerprintingReiner Schaumann, Franziska Laurin, Arne C Rodloff
Current Microbiology|February 2, 2006
Bacteroides fragilis group: trends in resistanceManfred Fille, Monica Mango, Matthias Lechner, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2012
In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kineticsReiner Schaumann, Matthias Funke, Eva Janssen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 1997
Is TNF-alpha a prognostic factor in patients with sepsis?Reiner Schaumann, Tilman Schlick, Martin Schaper, et al.
Journal of Medical Microbiology|July 15, 2005
Activity of moxifloxacin against Bacteroides fragilis and Escherichia coli in an in vitro pharmacokinetic/pharmacodynamic model employing pure and mixed culturesReiner Schaumann, Ellie Jc Goldstein, Jochen Forberg, et al.
European Journal of Medical Research|November 19, 2002
Effects of Porphyromonas gingivalis on the activation of mouse macrophages by lipopolysaccharideReiner Schaumann, K Sommer, C Retzlaff, et al.
The Journal of Antimicrobial Chemotherapy|January 20, 2004
Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coliReiner Schaumann, Rosemarie Blatz, Joerg Beer, et al.
Anaerobe|August 5, 2006
Therapeutic efficacy of moxifloxacin in a murine model of severe systemic mixed infection with Escherichia coli and Bacteroides fragilisChristiane Eckhardt, Kristina Fickweiler, Reiner Schaumann, et al.
The Thoracic and Cardiovascular Surgeon|May 3, 2014
72 hours standby time of wet-primed cardiopulmonary bypass circuits: a microbiological quality assurance studySebastian Schulz-Stübner, Cornelia Schorer, Jürgen Ennker, et al.
International Journal of Medical Microbiology : IJMM|September 8, 2014
Inguinal skin colonization with multidrug-resistant bacteria among residents of elderly care facilities: frequency, persistence, molecular analysis and clinical impactClaudia Ruscher, Yvonne Pfeifer, Franziska Layer, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
International Journal of Hygiene and Environmental Health|November 6, 2007
Molecular typing of clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and random primer PCR fingerprintingReiner Schaumann, Franziska Laurin, Arne C Rodloff
Current Microbiology|February 2, 2006
Bacteroides fragilis group: trends in resistanceManfred Fille, Monica Mango, Matthias Lechner, et al.
Antimicrobial Agents and Chemotherapy|March 21, 2012
In vitro activities of clindamycin, imipenem, metronidazole, and piperacillin-tazobactam against susceptible and resistant isolates of Bacteroides fragilis evaluated by kill kineticsReiner Schaumann, Matthias Funke, Eva Janssen, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 1997
Is TNF-alpha a prognostic factor in patients with sepsis?Reiner Schaumann, Tilman Schlick, Martin Schaper, et al.
Journal of Medical Microbiology|July 15, 2005
Activity of moxifloxacin against Bacteroides fragilis and Escherichia coli in an in vitro pharmacokinetic/pharmacodynamic model employing pure and mixed culturesReiner Schaumann, Ellie Jc Goldstein, Jochen Forberg, et al.
European Journal of Medical Research|November 19, 2002
Effects of Porphyromonas gingivalis on the activation of mouse macrophages by lipopolysaccharideReiner Schaumann, K Sommer, C Retzlaff, et al.
The Journal of Antimicrobial Chemotherapy|January 20, 2004
Effect of moxifloxacin versus imipenem/cilastatin treatment on the mortality of mice infected intravenously with different strains of Bacteroides fragilis and Escherichia coliReiner Schaumann, Rosemarie Blatz, Joerg Beer, et al.
Anaerobe|August 5, 2006
Therapeutic efficacy of moxifloxacin in a murine model of severe systemic mixed infection with Escherichia coli and Bacteroides fragilisChristiane Eckhardt, Kristina Fickweiler, Reiner Schaumann, et al.
The Thoracic and Cardiovascular Surgeon|May 3, 2014
72 hours standby time of wet-primed cardiopulmonary bypass circuits: a microbiological quality assurance studySebastian Schulz-Stübner, Cornelia Schorer, Jürgen Ennker, et al.
International Journal of Medical Microbiology : IJMM|September 8, 2014
Inguinal skin colonization with multidrug-resistant bacteria among residents of elderly care facilities: frequency, persistence, molecular analysis and clinical impactClaudia Ruscher, Yvonne Pfeifer, Franziska Layer, et al.
Pageof 3